News Quantified

PCRX – pacira biosciences, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care

Pacira BioSciences (NASDAQ:PCRX) was upgraded by analysts at Barclays PLC to a "hold" rating.

Pacira BioSciences (NASDAQ:PCRX) had its "sell (d+)" rating reaffirmed by analysts at Weiss Ratings.

Pacira BioSciences (NASDAQ:PCRX) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $27.00 price target on the stock.

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4.5%

BEAT

-0.6%

BEAT

0.8%

BEAT

-5.2%

BEAT

Form 4 Pacira BioSciences, Inc. For: Dec 09 Filed by: Cross Shawn

Form 144 Pacira BioSciences, Inc. Filed by: Cross Shawn

Form 144 Pacira BioSciences, Inc. Filed by: Cross Shawn

Form 4 Pacira BioSciences, Inc. For: Nov 17 Filed by: SLONIN JONATHAN

Form 144 Pacira BioSciences, Inc. Filed by: SLONIN JONATHAN

Top News Gainers

4/17 Pacira Biosciences Inc (NASDAQ: PCRX) had its "buy" rating re-affirmed by analysts at Northland Securities. They now have a $50.00 price target on the stock. 13.0%

3/23 Pacira Biosciences Inc (NASDAQ: PCRX) had its price target lowered by analysts at Piper Sandler from to . 6.6%

3/12 Form 4 Pacira BioSciences, Inc. For: Mar 11 Filed by: WINSTON ROY 6.0%

10/3 Pacira Biosciences Inc (NASDAQ: PCRX) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 5.7%

2/10 Form SC 13G/A Pacira BioSciences, Inc. Filed by: BlackRock Inc. 5.0%

6/6 Form 4 Pacira BioSciences, Inc. For: Jun 05 Filed by: Brege Laura 4.6%

4/30 Pacira to Report First Quarter 2020 Financial Results on Thursday May 7, 2020 4.5%

4/24 Form DEF 14A Pacira BioSciences, Inc. For: Jun 08 3.6%

3/17 Pacira Biosciences Inc (NASDAQ: PCRX) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 3.5%

11/7 Pacira Biosciences Inc (NASDAQ: PCRX) had its "hold" rating re-affirmed by analysts at Cowen Inc. They now have a $41.00 price target on the stock. 3.3%

Top News Decliners

3/20 Pacira Biosciences Inc (NASDAQ: PCRX) was upgraded by analysts at SVB Leerink LLC from a "market perform" rating to an "outperform" rating. -12.1%

3/23 Pacira Biosciences Inc (NASDAQ: PCRX) had its price target lowered by analysts at Royal Bank of Canada from $65.00 to $56.00. They now have an "outperform" rating on the stock. -9.6%

3/9 Pacira BioSciences to Present at the 2020 Barclays Global Healthcare Conference -6.8%

2/20 Pacira Biosciences Inc (NASDAQ: PCRX) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -3.6%

8/8 Q2/2019 6/30/2019 EPS 0.410 ZacksConsensus 0.140 ActVsEst 0.270 - Beat -3.4%

9/24 Pacira BioSciences Set to Join S&P SmallCap 600 -3.3%

6/5 Form 4 Pacira BioSciences, Inc. For: Jun 03 Filed by: Scranton Richard -3.2%

2/21 Form 10-K Pacira BioSciences, Inc. For: Dec 31 -3.1%

9/30 Form SC 13G Pacira BioSciences, Inc. Filed by: INTEGRATED CORE STRATEGIES (US) LLC -3.0%

1/7 EXPAREL Achieves Primary and Key Secondary Endpoints in Phase 4 CHOICE Study in Cesarean Section Patients -2.9%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day